New FDA drug approvals hit their stride in 2018...Cancer drugs came out tops with 16 approvals ..The number of rare diseases approvals almost matched that of the cancer approvals ..So what was behind the boost of approvals in 2018 ,analyst Jon Miller says it's hard to say it's a trend ,that said ,the FDA over the last couple of years has been increasingly concillary ,and I don't mean that they are letting bad drugs thru , but they have been putting less resistance to certain things ..The FDA is becoming more willing especially in rare disease and restricted patient population with high met needs on what might have counted as thin evidence 5-8 years ago ......
- Forums
- ASX - By Stock
- MSB
- MSB Trading - 2019
MSB Trading - 2019, page-48
-
- There are more pages in this discussion • 4,377 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.45 |
Change
-0.030(2.03%) |
Mkt cap ! $1.655B |
Open | High | Low | Value | Volume |
$1.48 | $1.51 | $1.43 | $6.613M | 4.498M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2482 | $1.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.46 | 27045 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2482 | 1.450 |
1 | 2574 | 1.440 |
1 | 15000 | 1.435 |
2 | 11400 | 1.430 |
1 | 15000 | 1.425 |
Price($) | Vol. | No. |
---|---|---|
1.455 | 14000 | 1 |
1.460 | 14000 | 1 |
1.465 | 14000 | 1 |
1.480 | 50134 | 1 |
1.485 | 40331 | 2 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |